Kaleido Biosciences, Inc. (KLDO)

Kaleido Biosciences Revenue

In the year 2021, Kaleido Biosciences had annual revenue of $1.10M with 13.23% growth. Kaleido Biosciences had revenue of $492.00K in the quarter ending December 31, 2021, with 102.47% growth.

• Revenue: 1.10M
• Revenue Growth: +13.23%
• P/S Ratio: 0.00
• Revenue / Employee: 14.53K
• Employees: 76
• Market Cap: 4.26K

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2021	1.10M	129.00K	13.23%
Dec 31, 2020	975.00K	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2021

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 6, 2026

Data Sources Report a data error